EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieÄquivalenzstudieOpen Access

Diagnostic Stewardship in Community-Acquired Pneumonia With Syndromic Molecular Testing

Dagfinn L Markussen, Sondre Serigstad, Christian Ritz, Siri T Knoop, Marit H Ebbesen, Daniel Faurholt-Jepsen, Lars Heggelund, Cornelis H van Werkhoven, Tristan W Clark, Rune O Bjørneklett, Øyvind Kommedal, Elling Ulvestad und 1 weitere

JAMA Network Open · 06.03.2024 · 7 (3) · e240830

DOI: 10.1001/jamanetworkopen.2024.0830 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, online erschienen am 06.03.2024. Verfasst von Dagfinn L Markussen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science, Bergen Integrated Diagnostic Stewardship Cluster, University of Bergen, Bergen, Norway. Hauptthemen laut MEDLINE: Community-Acquired Infections, Pneumonia, Respiratory Tract Infections. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Lower respiratory tract (LRT) infections, including community-acquired pneumonia (CAP), are a leading cause of hospital admissions and mortality. Molecular tests have the potential to optimize treatment decisions and management of CAP, but limited evidence exists to support their routine use.

Objective

To determine whether the judicious use of a syndromic polymerase chain reaction (PCR)-based panel for rapid testing of CAP in the emergency department (ED) leads to faster, more accurate microbiological test result–based treatment. Design, Setting, and Participants This parallel-arm, single-blinded, single-center, randomized clinical superiority trial was conducted between September 25, 2020, and June 21, 2022, in the ED of Haukeland University Hospital, a large tertiary care hospital in Bergen, Norway. Adult patients who presented to the ED with suspected CAP were recruited. Participants were randomized 1:1 to either the intervention arm or standard-of-care arm. The primary outcomes were analyzed according to the intention-to-treat principle.

Intervention

Patients randomized to the intervention arm received rapid syndromic PCR testing (BioFire FilmArray Pneumonia plus Panel; bioMérieux) of LRT samples and standard of care. Patients randomized to the standard-of-care arm received standard microbiological diagnostics alone. Main Outcomes and Measures The 2 primary outcomes were the provision of pathogen-directed treatment based on a microbiological test result and the time to provision of pathogen-directed treatment (within 48 hours after randomization).

Results

There were 374 patients (221 males [59.1%]; median (IQR) age, 72 [60-79] years) included in the trial, with 187 in each treatment arm. Analysis of primary outcomes showed that 66 patients (35.3%) in the intervention arm and 25 (13.4%) in the standard-of-care arm received pathogen-directed treatment, corresponding to a reduction in absolute risk of 21.9 (95% CI, 13.5-30.3) percentage points and an odds ratio for the intervention arm of 3.53 (95% CI, 2.13-6.02; P < .001). The median (IQR) time to provision of pathogen-directed treatment within 48 hours was 34.5 (31.6-37.3) hours in the intervention arm and 43.8 (42.0-45.6) hours in the standard-of-care arm (mean difference, −9.4 hours; 95% CI, −12.7 to −6.0 hours; P < .001). The corresponding hazard ratio for intervention compared with standard of care was 3.08 (95% CI, 1.95-4.89). Findings remained significant after adjustment for season. Conclusions and Relevance Results of this randomized clinical trial indicated that routine deployment of PCR testing for LRT pathogens led to faster and more targeted microbial treatment for patients with suspected CAP. Rapid molecular testing could complement or replace selected standard, time-consuming, laboratory-based diagnostics. Trial Registration ClinicalTrials.gov Identifier: NCT04660084

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Community-Acquired InfectionsPneumoniaRespiratory Tract InfectionsAgedHumansMaleEmergency Service, HospitalHospitalizationMiddle Aged

Autor:innen und Institutionen

  • Department of Clinical Science, Bergen Integrated Diagnostic Stewardship Cluster, University of Bergen, Bergen, Norway.
  • Emergency Care Clinic, Haukeland University Hospital, Bergen, Norway.
  • Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.
  • Department of Microbiology, Haukeland University Hospital, Bergen, Norway.
  • Department of Internal Medicine, Vestre Viken Hospital Trust, Drammen, Norway.

Zitieren

APA

Markussen, D. L., Serigstad, S., Ritz, C., Knoop, S. T., Ebbesen, M. H., Faurholt-Jepsen, D., Heggelund, L., van Werkhoven, C. H., Clark, T. W., Bjørneklett, R. O., Kommedal, Ø., Ulvestad, E., & Grewal, H. M. S. (2024). Diagnostic Stewardship in Community-Acquired Pneumonia With Syndromic Molecular Testing. JAMA Network Open, 7(3), e240830. https://doi.org/10.1001/jamanetworkopen.2024.0830

Vancouver

Markussen DL, Serigstad S, Ritz C, Knoop ST, Ebbesen MH, Faurholt-Jepsen D, et al. Diagnostic Stewardship in Community-Acquired Pneumonia With Syndromic Molecular Testing. JAMA Network Open. 2024;7(3):e240830. doi:10.1001/jamanetworkopen.2024.0830

BibTeX
@article{Markussen2024,
  author = {Markussen, Dagfinn L and Serigstad, Sondre and Ritz, Christian and Knoop, Siri T and Ebbesen, Marit H and Faurholt-Jepsen, Daniel and Heggelund, Lars and van Werkhoven, Cornelis H and Clark, Tristan W and Bjørneklett, Rune O and Kommedal, Øyvind and Ulvestad, Elling and Grewal, Harleen M S},
  title = {Diagnostic Stewardship in Community-Acquired Pneumonia With Syndromic Molecular Testing},
  journal = {JAMA Network Open},
  year = {2024},
  volume = {7},
  number = {3},
  pages = {e240830},
  doi = {10.1001/jamanetworkopen.2024.0830}
}
Kostenlos starten →